Alchemy Health

Alchemy Health is a healthcare technology company that provides the physical, clinical, and digital infrastructure for safety-net clinics to establish and operate in-house pharmacies. Focused on clinics serving patients with HIV and Hepatitis C (HCV), the company leverages the 340B Drug Pricing Program to help clinics reclaim control of their pharmacy programs and improve patient access to life-saving medications. Alchemy's platform includes ROI analysis, physical setup, staffing, and digital tools to manage operations, as well as clinical pharmacy programs to expand patient outreach. The company was founded in 2023 and is backed by prominent investors including Andreessen Horowitz (a16z) Bio + Health.